Literature DB >> 31989581

Anabolic androgenic steroid abuse in the United Kingdom: An update.

Carrie Mullen1, Benjamin J Whalley2, Fabrizio Schifano3, Julien S Baker4.   

Abstract

Anabolic androgenic steroids (AASs) are prescribed for medical conditions related to low testosterone. Abuse of AASs has surged as they become recognised as potent image enhancement drugs. The primary goal of most abusers is to obtain a more attractive outward appearance. Abuse is complex. There are a vast range of AAS substances illegally available, the nature of their true composition is difficult to evaluate. Users follow dosing patterns which incorporate a number of different AASs, in addition to other pharmaceutical substances believed to complement the desired physical effects or manage unwanted effects. Animal work and medical case reports suggest potential to cause serious hepatotoxicity, plus possible neurotoxicity, nephrotoxicity and damage to the cardiovascular and reproductive systems. As the long-term AASs users reach maturity, further controlled experimentation, with larger sample sizes, is required. Data gathering should be directed towards the most vulnerable group of AAS users, females and adolescent boys.
© 2020 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31989581      PMCID: PMC7174889          DOI: 10.1111/bph.14995

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  118 in total

1.  The development of focal segmental glomerulosclerosis secondary to anabolic steroid abuse.

Authors:  Patrick Harrington; Galil Ali; Anthony Chan
Journal:  BMJ Case Rep       Date:  2011-12-02

2.  Cholestasis secondary to anabolic steroid use in young men.

Authors:  Ahmed M Elsharkawy; Stuart McPherson; Steven Masson; Alastair D Burt; Robert T Dawson; Mark Hudson
Journal:  BMJ       Date:  2012-02-02

3.  Aggression and body image concerns among anabolic androgenic steroid users, contemplators, and controls in Norway.

Authors:  Ida Heimly Jenssen; Kim Berg Johannessen
Journal:  Body Image       Date:  2014-09-27

4.  Anabolic-androgenic steroids impair set-shifting and reversal learning in male rats.

Authors:  Kathryn G Wallin; Ruth I Wood
Journal:  Eur Neuropsychopharmacol       Date:  2015-01-20       Impact factor: 4.600

Review 5.  Anabolic androgenic steroid abuse in the United Kingdom: An update.

Authors:  Carrie Mullen; Benjamin J Whalley; Fabrizio Schifano; Julien S Baker
Journal:  Br J Pharmacol       Date:  2020-03-03       Impact factor: 8.739

6.  Subchronic steroid administration induces long lasting changes in neurochemical and behavioral response to cocaine in rats.

Authors:  Sanna Kailanto; Aino Kankaanpää; Timo Seppälä
Journal:  Steroids       Date:  2011-07-02       Impact factor: 2.668

7.  Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction.

Authors:  Aaron L Baggish; Rory B Weiner; Gen Kanayama; James I Hudson; Michael H Picard; Adolph M Hutter; Harrison G Pope
Journal:  Circ Heart Fail       Date:  2010-04-27       Impact factor: 8.790

Review 8.  Anabolic steroids and cardiovascular risk.

Authors:  Peter Angell; Neil Chester; Danny Green; John Somauroo; Greg Whyte; Keith George
Journal:  Sports Med       Date:  2012-02-01       Impact factor: 11.136

Review 9.  Anabolic androgenic steroids and forebrain GABAergic transmission.

Authors:  L P Henderson; C A A Penatti; B L Jones; P Yang; A S Clark
Journal:  Neuroscience       Date:  2005-11-28       Impact factor: 3.590

10.  Defining the Construct of Synthetic Androgen Intoxication: An Application of General Brain Arousal.

Authors:  Tom Hildebrandt; Ashley Heywood; Daniel Wesley; Kurt Schulz
Journal:  Front Psychol       Date:  2018-03-29
View more
  9 in total

Review 1.  Anabolic androgenic steroid abuse in the United Kingdom: An update.

Authors:  Carrie Mullen; Benjamin J Whalley; Fabrizio Schifano; Julien S Baker
Journal:  Br J Pharmacol       Date:  2020-03-03       Impact factor: 8.739

Review 2.  The medicalization of testosterone: reinventing the elixir of life.

Authors:  Thiago Gagliano-Jucá; Mauricio Alvarez; Shehzad Basaria
Journal:  Rev Endocr Metab Disord       Date:  2022-08-23       Impact factor: 9.306

3.  Fake anabolic androgenic steroids on the black market - a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature.

Authors:  Raphael Magnolini; Luis Falcato; Alessio Cremonesi; Dominique Schori; Philip Bruggmann
Journal:  BMC Public Health       Date:  2022-07-17       Impact factor: 4.135

4.  ADHD symptoms and use of anabolic androgenic steroids among male weightlifters.

Authors:  Emilie Kildal; Bjørnar Hassel; Astrid Bjørnebekk
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

Review 5.  Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review.

Authors:  Giuseppe Davide Albano; Francesco Amico; Giuseppe Cocimano; Aldo Liberto; Francesca Maglietta; Massimiliano Esposito; Giuseppe Li Rosi; Nunzio Di Nunno; Monica Salerno; Angelo Montana
Journal:  Healthcare (Basel)       Date:  2021-01-19

6.  Aescin Protects against Experimental Benign Prostatic Hyperplasia and Preserves Prostate Histomorphology in Rats via Suppression of Inflammatory Cytokines and COX-2.

Authors:  Mohamed Raafat; Amr A Kamel; Alaa H Shehata; Al-Shaimaa F Ahmed; Asmaa M A Bayoumi; Rabab A Moussa; Mohammed A S Abourehab; Mahmoud El-Daly
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-22

7.  Appearance and performance-enhancing drugs and supplements, eating disorders, and muscle dysmorphia among gender minority people.

Authors:  Jason M Nagata; F Hunter McGuire; Jason M Lavender; Tiffany A Brown; Stuart B Murray; Richard E Greene; Emilio J Compte; Annesa Flentje; Micah E Lubensky; Juno Obedin-Maliver; Mitchell R Lunn
Journal:  Int J Eat Disord       Date:  2022-03-30       Impact factor: 5.791

Review 8.  Anabolic androgenic steroid-induced liver injury: An update.

Authors:  Ana Petrovic; Sonja Vukadin; Renata Sikora; Kristina Bojanic; Robert Smolic; Davor Plavec; George Y Wu; Martina Smolic
Journal:  World J Gastroenterol       Date:  2022-07-14       Impact factor: 5.374

9.  No association between psychiatric symptoms and doses of anabolic steroids in a cohort of male and female bodybuilders.

Authors:  Julio X Amaral; Andrea C Deslandes; Monica C Padilha; Leonardo Vieira Neto; Luiz E Osorio; Francisco Radler Aquino Neto; Marcelo S Cruz
Journal:  Drug Test Anal       Date:  2022-02-21       Impact factor: 3.234

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.